Retirement Wealth Solutions’s AbbVie ABBV Stock Holding History

Retirement Wealth Solutions’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47.8K	Hold	190	–	–	0.03%	102
2026 Q1	$41.3K	Sell	190 -10	-5%	-$2.22K	0.03%	95
2025 Q4	$45.6K	Hold	200	–	–	0.03%	103
2025 Q3	$46.2K	Buy	200 +1	+0.5%	+$204	0.03%	100
2025 Q2	$37K	Hold	199	–	–	0.03%	108
2025 Q1	$41.7K	Hold	199	–	–	0.03%	91
2024 Q4	$34.9K	Buy	+199	New	+$36.6K	0.03%	103

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Retirement Wealth Solutions's ABBV Position: Q2 2026 in Review

Retirement Wealth Solutions held its AbbVie (ABBV) position steady in Q2 2026 at 190 shares worth $47.8K. The position accounts for 0.03% of the portfolio, ranked #102.

Retirement Wealth Solutions first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Retirement Wealth Solutions held 190 shares of AbbVie worth $47.8K as of Q2 2026.
Retirement Wealth Solutions left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.03% of Retirement Wealth Solutions's portfolio in Q2 2026, its #102 holding.
Retirement Wealth Solutions first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Retirement Wealth Solutions's 13F filing for Q2 2026, filed 7 Jul 2026.